Dr. Goodenowe has been invited to give a scientific presentation on October 26, 2017, at the Campus Alberta Neuroscience Symposium, Neurotechnology for Discovery and Translation. The title of Dr. Goodenowe’s talk is, “Bipolar Disorder: Biology, serum biomarkers, and opportunities to improve patient management”. Dr. Goodenowe’s talk will provide the audience with an overview on the biochemical dysfunctions present in bipolar disorder, the potential for serum biomarkers that can identify and differentiate bipolar disorder from major depressive disorder and schizophrenia and how biomarkers could be used to improve patient management through better and more efficient diagnosis.
- July 31, 2017
